CollPlant Biotechnologies (CLGN) Current Assets (2017 - 2025)

CollPlant Biotechnologies' Current Assets history runs 9 years deep, the most recent figure standing at $6.7 million for Q4 2025.

• Quarterly Current Assets fell 99.95% year-over-year to $6.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $6.7 million (down 99.95% YoY) and the FY2025 annual result came in at $6.7 million, down 99.95% from the prior year.
• Current Assets was $6.7 million for Q4 2025 at CollPlant Biotechnologies, down from $12.6 million in the prior quarter.
• Across five years, Current Assets topped out at $45087.0 billion in Q4 2021 and bottomed at $6.7 million in Q4 2025.
• A 5-year average of $2514.2 billion and a median of $45.3 million in 2021 frame the typical range for Current Assets.
• Annual changes were most pronounced in 2021 — Current Assets soared 794344508.88% — and 2025, when it plunged 99.95%.
• CollPlant Biotechnologies' Current Assets stood at $45087.0 billion in 2021, then sank by 99.93% to $31.7 billion in 2022, then slumped by 99.91% to $28.0 million in 2023, then soared by 46934.47% to $13.2 billion in 2024, then plunged by 99.95% to $6.7 million in 2025.
• Business Quant data shows CLGN's Current Assets at $6.7 million in Q4 2025, $12.6 million in Q2 2025, and $13.2 billion in Q4 2024.